Gastroenterology & Hepatology Clinical Trials

Statistical methods in gastroenterology & hepatology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All gastroenterology & hepatology trials

578 results

• Detection of Barrett s Esophagus in Patients Without GERD Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Detection of Barrett s Esophagus in Patients Without GERD Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04880044).Phase NAResults postedn = 132NCT04880044
• Diagnosis of Acute Appendicitis: Low-dose Computed Tomography (CT) Versus Standard-dose CT: Complete Statistical AnalysisIndependent statistical analysis of Diagnosis of Acute Appendicitis: Low-dose Computed Tomography (CT) Versus Standard-dose CT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 891NCT00913380
• DietGERDIndependent statistical analysis of Dietary Carbohydrate and GERD in Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02384551).Phase NAResults postedn = 150NCT02384551
• DIGESTIndependent statistical analysis of Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01285557).Phase 3Results postedn = 361NCT01285557
• Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?: Complete Statistical AnalysisIndependent statistical analysis of Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 188NCT00486902
• Does Improving Vagal Tone Increase Mitochondrial Bioenergetics: Complete Statistical AnalysisIndependent statistical analysis of Does Improving Vagal Tone Increase Mitochondrial Bioenergetics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03931330).Phase NAResults postedn = 8NCT03931330
• Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett’s Esophagus Following Ablation?: Complete Statistical AnalysisIndependent statistical analysis of Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 30NCT01093755
• Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 1Results postedn = 27NCT01761240
• Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1/2Results postedn = 70NCT02532764
• Dose the Saline Reduce the Mucus Production When Water Exchange Colonoscopy is Used?: Complete Statistical AnalysisIndependent statistical analysis of Dose the Saline Reduce the Mucus Production When Water Exchange Colonoscopy is Used?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 301NCT04769739
• Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation: Complete Statistical AnalysisIndependent statistical analysis of Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 192NCT02314936
• Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 82NCT00762073
• Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 2Results postedn = 64NCT01054729
• Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy: primary endpoint results, effect estimate with confidence…Phase 3Results postedn = 155NCT01156142
• DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 1Results postedn = 12NCT03368196
• Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1Results postedn = 16NCT01094704
• EASE SBS 1Independent statistical analysis of Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 106NCT03690206
• EBR/GZR for HCV-1b Patients Receiving Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of EBR/GZR for HCV-1b Patients Receiving Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03420300).Phase 4Results postedn = 40NCT03420300
• eCareIndependent statistical analysis of Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 538NCT04739696
• Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…Phase NAResults postedn = 239NCT00450424
• Effect IV Ibuprofen and Inflammatory Responses: Complete Statistical AnalysisIndependent statistical analysis of Effect IV Ibuprofen and Inflammatory Responses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01938040).Phase 4Results postedn = 60NCT01938040
• Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate: Complete Statistical AnalysisIndependent statistical analysis of Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 173NCT01568112
• Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS): Complete Statistical AnalysisIndependent statistical analysis of Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 36NCT01253408
• Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 4Results postedn = 106NCT00838682
• Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 23NCT01031706
• Effect of Increlex® on Children With Crohn Disease: Complete Statistical AnalysisIndependent statistical analysis of Effect of Increlex® on Children With Crohn Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00764699).Phase 2/3Results postedn = 3NCT00764699
• Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562): Complete Statistical AnalysisIndependent statistical analysis of Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562): primary endpoint results, effect estimate with confidence interval, sample-size…Phase NAResults postedn = 250NCT00705224
• Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 101NCT02425111
• Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated Diarrhea: Complete Statistical AnalysisIndependent statistical analysis of Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated Diarrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 214NCT01058356
• Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy: Complete Statistical AnalysisIndependent statistical analysis of Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 15NCT02163837
• Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc: Complete Statistical AnalysisIndependent statistical analysis of Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc: primary endpoint results, effect estimate with…Phase 4Results postedn = 596NCT00289731
• Effect of Tai Chi as Treatment for IBS-C: Complete Statistical AnalysisIndependent statistical analysis of Effect of Tai Chi as Treatment for IBS-C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04132804).Phase NAResults postedn = 31NCT04132804
• Effectiveness and Implementation of mPATH-CRC: Complete Statistical AnalysisIndependent statistical analysis of Effectiveness and Implementation of mPATH-CRC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03843957).Phase NAResults postedn = 77,145NCT03843957
• Effectiveness of Monovalent Rotavirus Vaccine (RV1): Complete Statistical AnalysisIndependent statistical analysis of Effectiveness of Monovalent Rotavirus Vaccine (RV1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01871038).Phase NAResults postedn = 362NCT01871038
• Effectiveness of Pulmozyme in Infants With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Effectiveness of Pulmozyme in Infants With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00179998).Phase 2Results postedn = 24NCT00179998
• Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination: Complete Statistical AnalysisIndependent statistical analysis of Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 14NCT02590068
• Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease: Complete Statistical AnalysisIndependent statistical analysis of Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 1NCT00529204
• Effects of Gastric Bypass on Blood Levels of Duloxetine: Complete Statistical AnalysisIndependent statistical analysis of Effects of Gastric Bypass on Blood Levels of Duloxetine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00989157).Phase 3Results postedn = 20NCT00989157
• Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF): Complete Statistical AnalysisIndependent statistical analysis of Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 10NCT03126370
• Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit: Complete Statistical AnalysisIndependent statistical analysis of Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 4Results postedn = 25NCT00844831
• Effects of Non Contact Low Frequency Ultrasound in Healing Venous Leg Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Effects of Non Contact Low Frequency Ultrasound in Healing Venous Leg Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 156NCT01549860
• Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 180NCT01665157
• Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 100NCT00686374
• Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 102NCT06591013
• Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04173429).Phase 4Results postedn = 64NCT04173429
• Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 265NCT01008410
• Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 281NCT01008423
• Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00737594).Phase 2Results postedn = 9NCT00737594
• Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096): Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096): primary endpoint results, effect…Phase 4Results postedn = 117NCT03111108
• Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 1NCT03139032

← All therapeutic areas